Hans-Peter Gerber
19Patents
13h-index
27Co-inventors
78Inventor score
Filing activity: Nov 15, 2002 → Feb 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7691977B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 67 | Active |
| US7758859B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 64 | Expired |
| US8309094B2 | Antibody-drug conjugates | Chemistry; Metallurgy | 43 | Active |
| US8586049B2 | Antibody-drug conjugates | Chemistry; Metallurgy | 38 | Active |
| US7267819B2 | Composition comprising and method of using angiopoietin-like protein 3 Angptl3 | Chemistry; Metallurgy | 33 | Expired |
| US7811785B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 27 | Expired |
| US8512699B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 21 | Active |
| US8470329B2 | Combination therapy with antibody-drug conjugates | Human Necessities | 20 | Active |
| US8263083B2 | Combination therapy with antibody-drug conjugates | Human Necessities | 19 | Active |
| US8492527B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 19 | Active |
| US8101177B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 17 | Active |
| US8242252B2 | CD19 binding agents and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US8092797B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 15 | Active |
| US10254286B2 | Methods for detecting 5T4-positive circulating tumor cells and methods of diagnosis of 5T4-positive cancer in a mammalian subject | Physics | 13 | Active |
| US8541376B2 | Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 | Chemistry; Metallurgy | 10 | Active |
| US9353177B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 8 | Active |
| US8975381B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 5 | Active |
| US9018357B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 4 | Active |
| US11833216B2 | Anti-EDB antibodies and antibody-drug conjugates | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.